These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6992450)

  • 21. Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo.
    Marchettini G; Corsini P; Massimini G
    Drugs Exp Clin Res; 1987; 13(1):51-6. PubMed ID: 3297594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental models for the study of hepatoprotection.
    Fehér J; Pollák Z; Sréter L; Toncsev H; Cornides A; Gógl A; Vereckei A
    Acta Physiol Hung; 1984; 64(3-4):401-7. PubMed ID: 6532127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anabolic steroids and the functional state of the liver (a survey of the literature)].
    Vokov NF
    Klin Med (Mosk); 1972 Dec; 50(12):63-7. PubMed ID: 4573926
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of pyrogenal in the overall treatment of infectious diseases (a review of the literature)].
    Zeĭgermakher GA
    Vrach Delo; 1980 Feb; (2):105-7. PubMed ID: 6989111
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytophotometric study of DNA in rabbit liver cells during experimental treatment of chronic hepatitis and liver cirrhosis.
    Leont'eva LI; Sherudilo AI; Iakobson GS
    Tsitologiia; 1971 May; 13(5):664-7. PubMed ID: 5561714
    [No Abstract]   [Full Text] [Related]  

  • 26. Morphological changes in the liver due to phenazone and its derivatives.
    Altmann HW
    Agents Actions Suppl; 1986; 19():267-79. PubMed ID: 3463183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the pathology-improving and jaundice-reducing effects of different prescriptions of blood-cooling and circulation-promoting prescriptions for 27 cases of severe icteric hepatitis].
    He JP; Wang CB; Zhu CW
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):147-9, 132. PubMed ID: 3416395
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrahepatic cholestasis in common chronic liver diseases.
    Jüngst C; Berg T; Cheng J; Green RM; Jia J; Mason AL; Lammert F
    Eur J Clin Invest; 2013 Oct; 43(10):1069-83. PubMed ID: 23927644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the effect of oxygen and cocarboxylase on the regenerative activity of the liver in experimental toxic hepatitis].
    Shafiev EK; Eĭtsen EF; Mirodzhov GK
    Arkh Patol; 1973; 35(11):58-62. PubMed ID: 4793230
    [No Abstract]   [Full Text] [Related]  

  • 30. [A contribution to the treatment of chronic liver diseases (author's transl)].
    Möller E; Schmitt R
    Med Klin; 1976 Oct; 71(43):1831-5. PubMed ID: 825708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid].
    Stiehl A
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():129-30. PubMed ID: 7483696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The treatment of hepatoses].
    Wallnöfer H
    Munch Med Wochenschr; 1972 Feb; 114(5):186-90. PubMed ID: 4110816
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
    Hennings G
    Arzneimittelforschung; 1979; 29(5):720-4. PubMed ID: 387044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corticosteroids and the liver. Metabolism and indications in liver diseases].
    Uribe M; Ramos MH
    Rev Invest Clin; 1983; 35(1):71-80. PubMed ID: 6346450
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
    Podymova SD; Nadinskaia MIu
    Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acid.
    Faust D; Fellbaum C; Zeuzem S; Dietrich CF
    Z Gastroenterol; 2003 Mar; 41(3):255-8. PubMed ID: 12664346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alcohol and liver diseases (review of the literature)].
    Skupnik AM; Mikunis RI
    Ter Arkh; 1974; 46(4):21-31. PubMed ID: 4610869
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased activity of enzymes for de novo pyrimidine biosynthesis after orotic acid administration.
    Bresnick E; Mayfield ED; Mossé H
    Mol Pharmacol; 1968 Mar; 4(2):173-80. PubMed ID: 5645613
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of ethyl linoleate on chronic liver diseases with special reference to lipid metabolism.
    Ito Y
    Nagoya J Med Sci; 1966 Dec; 29(2):167-89. PubMed ID: 5984527
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pathology of liver transplantation: Lausanne experience].
    Fontolliet C; Mosimann F; Genton A
    Rev Med Suisse Romande; 1992 Feb; 112(2):135-40. PubMed ID: 1546240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.